SLRN - long - catalyst and huge gapAcelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates.
This is not a financial advice!
Upcoming catalyst on